|
Market Closed -
Nasdaq
01:30:00 15/08/2025 am IST
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 332.12Cr 291.44Cr 275.25Cr 250.84Cr 469.56Cr 32TCr 472.91Cr 3.29TCr 1.28TCr 16TCr 1.25TCr 1.22TCr 52TCr | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 347.73Cr 305.13Cr 288.18Cr 262.63Cr 491.62Cr 33TCr 495.13Cr 3.45TCr 1.34TCr 17TCr 1.31TCr 1.28TCr 55TCr | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/25/30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/25/30 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/25/30 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/25/30 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/25/24 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 3 years | 82.15 |  | 101.02 |
| 5 years | 69.36 | | 188.88 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Chief Executive Officer | 5,20,347 | 1.5886% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 223.64Cr 196.24Cr 185.34Cr 168.9Cr 316.18Cr 21TCr 318.44Cr 2.22TCr 859.04Cr 11TCr 839.67Cr 821.51Cr 35TCr | 234.83Cr 206.07Cr 194.62Cr 177.36Cr 332.01Cr 23TCr 334.38Cr 2.33TCr 902.04Cr 11TCr 881.7Cr 862.63Cr 37TCr |
| Net income | -97.47L -85.53L -80.78L -73.62L -1.38Cr -93Cr -1.39Cr -9.67Cr -3.74Cr -48Cr -3.66Cr -3.58Cr -153.39Cr | 4.32Cr 3.79Cr 3.58Cr 3.27Cr 6.11Cr 414.35Cr 6.16Cr 43Cr 17Cr 211.68Cr 16Cr 16Cr 680.32Cr |
| Net Debt | 36Cr 32Cr 30Cr 27Cr 51Cr 3.46TCr 51Cr 357.78Cr 138.58Cr 1.77TCr 135.45Cr 132.52Cr 5.68TCr | 16Cr 14Cr 13Cr 12Cr 22Cr 1.5TCr 22Cr 154.77Cr 60Cr 764.14Cr 59Cr 57Cr 2.46TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
